STL Volume 6 Number 6
Update on Drugs and Drug News: March 2001
Update on: Caspofungin Acetate Cancidas 5% Minoxidil Topical Solution Mequinol 2%, Tretinoin 0.1% Solagé Topical Solution Biologically Active Dressing Composite Cultured Skin (CCS) Xtrac Excimer Laser System
Imiquimod Applied Topically: A Novel Immune Response Modifier
Imiquimod (S-26308, R-837) (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4 amine), an immune response modifier, was approved as a 5% cream (Aldara, 3M Pharmaceuticals) by the US FDA in February 1997, for the treatment of genital and perianal warts.
